In vivo Cell-Specific Exosome Analysis

体内细胞特异性外泌体分析

基本信息

  • 批准号:
    10398194
  • 负责人:
  • 金额:
    $ 23.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Exosomes are small single-membrane secreted organelles of approximately 30-150 nm in diameter that are secreted by most, if not all cells. There is a growing appreciation that exosomes are an important part of inter-cellular communication and that cargo carried by exosomes transmit a variety of signaling properties from their cell of origin to cells that receive exosome cargo. Further, the exosome cargo released from a specific cell-type may reflect the physiologic state of that particular cell population. Most studies on exosomes rely on isolating exosomes from cultured cells or cell clusters in vitro, or bulk exosome isolation from in vivo sampling of biological fluids (such as plasma). However, there exist no simple tools that allow to in vivo isolate and examine exosomes that can be traced back to a specific cell of origin and which can be sampled longitudinally over time within the same organism. Thus, we have little information on how exosomes and their cargo released from a certain cell changes with ageing during the course of the life of an organism or how the exosome cargo may change if a particular cell-type responds to increased functional demand and/or injury. To address these questions, we have generated a mouse model that permits conditional and cell-selective genetic labeling of exosomes through expression of an engineered exosome surface marker. We have used a cDNA cassette in which the coding sequence of a green-fluorescent tag (pHluorin) is inserted into the first extracellular domain of the tetraspanin CD63, which is highly enriched in and expressed on the surface of exosomes. We have inserted this cassette into the Rosa26 locus allowing it to be conditionally expressed in a cell-specific manner after CRE-mediated removal of upstream transcriptional stop sequences (= R26- StopLoxP-CD63-pHluorin mouse). From plasma of these mice, using an antibody that recognizes pHluorin antigen, we can isolate and capture exosomes that can be traced back to their cell of origin. This unique mouse model represents a significant advance over existing means to study exosomes in vivo in a cell-selective manner. We have chosen to study exosomes released from pancreatic ß-cells, as these cells are known to undergo distinct functional and molecular changes with ageing and under different physiologic and pathologic conditions. In this exploratory proposal we aim to use our model system to examine whether and how the exosome cargo from pancreatic ß-cells in mice changes over their lifetime and during circumstances of altered metabolic demand. At the molecular level we will focus our proof-of-principle studies on examining changes in RNA levels in ß-cells and in circulating ß-cell-derived exosomes. The outcomes of these studies will increase our knowledge on whether exosomes accurately reflect the age and functional state of the pancreatic ß-cell and whether exosomes and their cargo could be utilized as diagnostic tools for early detection of cellular dysfunction and response to treatment.
外泌体是直径约30-150 nm的小的单膜分泌细胞器 大多数细胞分泌的蛋白质。越来越多的人认识到,外泌体是细胞间通讯的重要部分,并且外泌体携带的货物将多种信号传导特性从其来源细胞传递到接收外泌体货物的细胞。此外,从特定细胞类型释放的外泌体货物可以反映该特定细胞群的生理状态。 外泌体的大多数研究依赖于从体外培养的细胞或细胞簇中分离外泌体,或从生物流体(如血浆)的体内取样中大量分离外泌体。然而,不存在允许体内分离和检查可以追溯到特定起源细胞并且可以在同一生物体内随时间纵向取样的外来体的简单工具。 因此,我们几乎没有关于在生物体的生命过程中,外泌体及其从特定细胞释放的货物如何随着衰老而变化的信息,或者如果特定细胞类型响应增加的功能需求和/或损伤,外泌体货物如何变化的信息。 为了解决这些问题,我们已经产生了一种小鼠模型,该模型允许通过表达工程化的外泌体表面标记物对外泌体进行条件性和细胞选择性遗传标记。我们已经使用了一个cDNA盒,其中绿色荧光标签(pHluorin)的编码序列插入到四跨膜蛋白CD 63的第一个胞外结构域中,四跨膜蛋白CD 63高度富集在外泌体表面并在外泌体表面表达。我们已经将该盒插入Rosa 26基因座中,使其在CRE介导的上游转录终止序列(= R26-R26)的去除后以细胞特异性方式条件性表达。 StopLoxP-CD 63-pHluorin小鼠)。从这些小鼠的血浆中,使用识别pHluorin抗原的抗体,我们可以分离和捕获可以追溯到其起源细胞的外泌体。这种独特的小鼠模型代表了以细胞选择性方式在体内研究外泌体的现有方法的显著进步。 我们选择研究从胰腺癌细胞释放的外泌体,因为已知这些细胞随着衰老以及在不同的生理和病理条件下经历不同的功能和分子变化。在这个探索性的建议中,我们的目标是使用我们的模型系统来检查来自小鼠胰腺β细胞的外泌体货物是否以及如何在其一生中以及在代谢需求改变的情况下发生变化。在分子水平上,我们将把我们的原理验证研究集中在检查 图10.在PBMC和循环PBMC来源的外泌体中的RNA水平。 这些研究的结果将增加我们对外泌体是否准确反映胰腺癌细胞的年龄和功能状态以及外泌体及其货物是否可用作早期检测细胞功能障碍和对治疗反应的诊断工具的知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mehboob A Hussain其他文献

Mehboob A Hussain的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mehboob A Hussain', 18)}}的其他基金

Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
2 型糖尿病期间 β 细胞中肠促胰岛素功能缺陷的机制
  • 批准号:
    10313849
  • 财政年份:
    2021
  • 资助金额:
    $ 23.4万
  • 项目类别:
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
2 型糖尿病期间 β 细胞中肠促胰岛素功能缺陷的机制
  • 批准号:
    10619654
  • 财政年份:
    2021
  • 资助金额:
    $ 23.4万
  • 项目类别:
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
2 型糖尿病期间 β 细胞中肠促胰岛素功能缺陷的机制
  • 批准号:
    10427438
  • 财政年份:
    2021
  • 资助金额:
    $ 23.4万
  • 项目类别:
In vivo Cell-Specific Exosome Analysis
体内细胞特异性外泌体分析
  • 批准号:
    10231459
  • 财政年份:
    2021
  • 资助金额:
    $ 23.4万
  • 项目类别:
Glucagon signaling in metabolic homeostasis
代谢稳态中的胰高血糖素信号传导
  • 批准号:
    10424554
  • 财政年份:
    2020
  • 资助金额:
    $ 23.4万
  • 项目类别:
Glucagon signaling in metabolic homeostasis
代谢稳态中的胰高血糖素信号传导
  • 批准号:
    10261596
  • 财政年份:
    2020
  • 资助金额:
    $ 23.4万
  • 项目类别:
Hepatic endocrine suppression of the pancreatic beta-cell
胰腺β细胞的肝脏内分泌抑制
  • 批准号:
    8817887
  • 财政年份:
    2014
  • 资助金额:
    $ 23.4万
  • 项目类别:
Hepatic endocrine suppression of the pancreatic beta-cell
胰腺β细胞的肝脏内分泌抑制
  • 批准号:
    9671615
  • 财政年份:
    2014
  • 资助金额:
    $ 23.4万
  • 项目类别:
Control of hepatic and b-cell function by co-activators
共激活剂对肝细胞和 B 细胞功能的控制
  • 批准号:
    8010071
  • 财政年份:
    2010
  • 资助金额:
    $ 23.4万
  • 项目类别:
High-Throughput Screen For FDA Approved Drugs That Amplify Beta-Cell Mass In Vivo
高通量筛选 FDA 批准的体内放大 β 细胞质量的药物
  • 批准号:
    8045193
  • 财政年份:
    2010
  • 资助金额:
    $ 23.4万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了